Skip to content
healthcare.dev

TOPICAINE 5

NDC 63135-581, LIDOCAINE 5%, gel, from ESBA LABORATORIES INC..

Product NDC
63135-581
Status
Listed
Labeler
ESBA LABORATORIES INC.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63135-581 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE5 g/100g

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
63135-581-0463135058104113 g in 1 TUBE (63135-581-04)
63135-581-10631350581101 TUBE in 1 BOX (63135-581-10) / 10 g in 1 TUBE
63135-581-30631350581301 TUBE in 1 BOX (63135-581-30) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63135-581 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63135-581 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63135-581. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.